Home > News > Bilcare buys Singapore's Singular ID for S$20m
January 4th, 2008
Bilcare buys Singapore's Singular ID for S$20m
Bilcare has acquired Singapore-based Singular ID for 20 million Singapore dollars, reports CNBC-TV18. The latter provides pharma counterfeit solutions.
Bilcare has been looking at advancing its technology, in terms of solutions for counterfeit drugs. Now, it has gone ahead and acquired a Singapore-based company called Singular ID. They had been looking at this particular company for sometime.
Singular ID is a very high technology company, which uses nanotechnology, in terms of developing solutions to minimize the use of counterfeit drugs, which is seen as a big menace for most of the pharmaceutical companies.
Law enforcement/Anti-Counterfeiting/Security/Loss prevention
A better hologram for fraud protection and wearable optics: Nanotechnology improves holographic capabilities by encoding light polarization May 16th, 2016
Russian scientists develop long-range secure quantum communication system April 13th, 2016
New laser technique promises super-fast and super-secure quantum cryptography April 7th, 2016
Record-breaking steel could be used for body armor, shields for satellites April 7th, 2016
Fast, stretchy circuits could yield new wave of wearable electronics May 30th, 2016
Automating DNA origami opens door to many new uses: Like 3-D printing did for larger objects, method makes it easy to build nanoparticles out of DNA May 30th, 2016
Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016
Scientists illuminate a hidden regulator in gene transcription: New super-resolution technique visualizes important role of short-lived enzyme clusters May 27th, 2016
GLOBALFOUNDRIES Completes Acquisition of IBM Microelectronics Business: Transaction adds differentiating technologies, world-class technologists, and intellectual property July 1st, 2015
Entest BioMedical, Inc. in Discussions to Acquire Nanotechnology Delivery System for Cancer Therapy June 3rd, 2015
Evident Thermoelectrics Acquires GMZ Energy: Investment Accelerates Launch Of Evident's Thermoelectric Modules For Waste Heat May 20th, 2015
Keysight Technologies Begins Trading as Independent Company November 3rd, 2014